Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
University of Pittsburgh Schools of the Health Sciences
Immune system pathway identified to fight allergens, asthma
May 21st, 2008
For the first time, researchers from the University of Pittsburgh School of Medicine have identified genetic components of dendritic cells that are key to asthma and allergy-related immune response malfunction. Targeting these elements could result in more effective drugs to treat allergic disorders and asthma, according to a study reported in the May edition of the journal Nature Medicine. Dendritic cells are vital to immune response in that they recognize, capture and introduce threatening organisms to T lymphocytes¯other immune cells that secrete potent proteins called cytokines that surround and destroy the invaders. However, the Pittsburgh team's study goes further...
Source: Immunotherapy Weekly (2008-05-21)
|
